Swarajya

Our View
HeadlinesMagazineVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief

Pfizer Covid-19 vaccine

Amid Surge In COVID Cases Due To Delta Variant, Israel Rolls Out Pfizer Vaccine's Booster Shot To At-Risk Adults
Amid Surge In COVID Cases Due To Delta Variant, Israel Rolls Out Pfizer Vaccine's Booster Shot To At-Risk AdultsIANSJul 13, 2021 04:10 PM +05:30 IST
India's Drug Regulator DCGI Exempts Local Bridging Trials For Foreign Vaccines Approved By WHO And Select Overseas Regulators
India's Drug Regulator DCGI Exempts Local Bridging Trials For Foreign Vaccines Approved By WHO And Select Overseas RegulatorsSwarajya StaffJun 2, 2021 11:01 AM +05:30 IST
Why Pfizer And Moderna CEOs Are  Recommending Covid-19 Vaccine Boosters, And Why Some Experts Don't Agree Yet
Why Pfizer And Moderna CEOs Are Recommending Covid-19 Vaccine Boosters, And Why Some Experts Don't Agree Yet Bhaswati Guha Majumder May 21, 2021 04:56 PM +05:30 IST
After Pfizer CEO, German Expert Suggests The Necessity Of A 3rd Vaccine Shot: Do We Really Need It? 
After Pfizer CEO, German Expert Suggests The Necessity Of A 3rd Vaccine Shot: Do We Really Need It? Bhaswati Guha Majumder May 17, 2021 06:46 PM +05:30 IST
Pfizer To Sell 50 Million Covid-19 Vaccine Doses In India By Third Quarter Of 2021: Report
Pfizer To Sell 50 Million Covid-19 Vaccine Doses In India By Third Quarter Of 2021: ReportSwarajya StaffMay 15, 2021 01:21 PM +05:30 IST
Pfizer Vaccine And Challenges Linked To Its Rollout In India
Pfizer Vaccine And Challenges Linked To Its Rollout In IndiaBhaswati Guha Majumder May 5, 2021 07:05 PM +05:30 IST
Pfizer Bullied South American Nations During Vaccine Negotiations, Demanded Military Bases As Collateral: Report
Pfizer Bullied South American Nations During Vaccine Negotiations, Demanded Military Bases As Collateral: ReportSwarajya StaffApr 13, 2021 02:18 PM +05:30 IST
Pfizer-BioNTech Covid-19 Vaccine Effective Against Highly Infectious Coronavirus Variant Discovered In UK, Finds Study
Pfizer-BioNTech Covid-19 Vaccine Effective Against Highly Infectious Coronavirus Variant Discovered In UK, Finds StudySwarajya StaffJan 21, 2021 12:16 PM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype